Anticytomegalovirus IgG avidity in pregnancy:: A 2-year prospective study

被引:21
作者
Bodéus, M [1 ]
Van Ranst, M [1 ]
Bernard, P [1 ]
Hubinont, C [1 ]
Goubau, P [1 ]
机构
[1] Univ Catholique Louvain, Dept Microbiol, Virol Unit, B-1200 Brussels, Belgium
关键词
avidity; cytomegalovirus; pregnancy;
D O I
10.1159/000065386
中图分类号
R71 [妇产科学];
学科分类号
100211 [妇产科学];
摘要
Objectives: To analyze the practical use of the anticyto-megalovirus IgG avidity and its impact on the follow-up of pregnancy. To evaluate the performance of IgG avidity to exclude the risk of congenital infection. Methods: 409 IgM-positive women without a documented seroconversion were prospectively followed. Data concerning the follow-up of the pregnancies were collected (amniotic fluid puncture and samples from the offspring). These observations were compared to those of 76 seroconversions during the same period. Results: High avidity excluding a primary infection within the past 3 months was observed in 270 women. As the gestational age was less than 3 months for 121 women, exclusion of a primary infection was achieved in 30% of the cases. The rate of amniotic fluid puncture was influenced by the serological result: high avidity (9%), low avidity (42%) and seroconversion (65%). Conclusions: A high avidity index during the first trimester of pregnancy could reasonably be considered as a good indicator of past infection and invasive prenatal diagnosis is not necessary. Nearly 70% of the IgM-positive women could be reassured if the first serology was systematically performed before 12 weeks of gestation. Copyright (C) 2002 S. Karger AG, Basel.
引用
收藏
页码:362 / 366
页数:5
相关论文
共 30 条
[1]
AVIDITIES OF IGG DIRECTED AGAINST VIRAL CAPSID ANTIGEN OR EARLY ANTIGEN - USEFUL MARKERS FOR SIGNIFICANT EPSTEIN-BARR-VIRUS SEROLOGY [J].
ANDERSSON, A ;
VETTER, V ;
KREUTZER, L ;
BAUER, G .
JOURNAL OF MEDICAL VIROLOGY, 1994, 43 (03) :238-244
[2]
DIFFERENTIATION OF PRIMARY CYTOMEGALOVIRUS-INFECTION FROM REACTIVATION USING THE UREA DENATURATION TEST FOR MEASURING ANTIBODY AVIDITY [J].
BLACKBURN, NK ;
BESSELAAR, TG ;
SCHOUB, BD ;
OCONNELL, KF .
JOURNAL OF MEDICAL VIROLOGY, 1991, 33 (01) :6-9
[3]
Bodéus M, 1999, PRENATAL DIAG, V19, P314, DOI 10.1002/(SICI)1097-0223(199904)19:4<314::AID-PD542>3.0.CO
[4]
2-H
[5]
Increased risk of cytomegalovirus transmission in utero during late gestation [J].
Bodéus, M ;
Hubinont, C ;
Goubau, P .
OBSTETRICS AND GYNECOLOGY, 1999, 93 (05) :658-660
[6]
Predictive value of maternal-IgG avidity for congenital human cytomegalovirus infection [J].
Bodéus, M ;
Goubau, P .
JOURNAL OF CLINICAL VIROLOGY, 1999, 12 (01) :3-8
[7]
Avidity of IgG antibodies distinguishes primary from non-primary cytomegalovirus infection in pregnant women [J].
Bodeus, M ;
Feyder, S ;
Goubau, P .
CLINICAL AND DIAGNOSTIC VIROLOGY, 1998, 9 (01) :9-16
[8]
ANTIVIRAL ANTIBODY-RESPONSES AND INTRAUTERINE TRANSMISSION AFTER PRIMARY MATERNAL CYTOMEGALOVIRUS-INFECTION [J].
BOPPANA, SB ;
BRITT, WJ .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (05) :1115-1121
[9]
Dussaix E, 1996, PATHOL BIOL, V44, P405
[10]
THE OUTCOME OF CONGENITAL CYTOMEGALOVIRUS-INFECTION IN RELATION TO MATERNAL ANTIBODY STATUS [J].
FOWLER, KB ;
STAGNO, S ;
PASS, RF ;
BRITT, WJ ;
BOLL, TJ ;
ALFORD, CA .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (10) :663-667